Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-851-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
OECD471: Salmonella typhimurium and Escherichia coli reverse mutation assay. The study was performed to assess the potential of the test item to induce gene mutations by means of two independent Salmonella typhimurium and Escherichia coli reverse mutation assays. Experiment I was performed as a plate incorporation assay. Since a negative result was obtained in this experiment, experiment II was performed as a pre-incubation assay. Reverse mutation assays determine the frequency at which an agent abolishes or suppresses the effect of the forward mutation.
The reversion of bacteria from growth-dependence on a particular amino acid to grow in the absence of that amino acid (reversion from auxotrophy to prototrophy) is the most widely used marker.
The Salmonella typhimurium histidine (his) and the Escherichia coli tryptophan (trp) reversion system measures his- → his+ and trp- → trp+ reversions, respectively. The Salmonella typhimurium and Escherichia coli strains are constructed to differentiate between base pair (TA 1535, TA 100, and WP2 uvrA) and frameshift (TA 1537, TA 98) mutations.
According to the direct plate incorporation or the pre-incubation method the bacteria are exposed to the test item with and without metabolic activation and plated on selective medium. After a suitable period of incubation, revertant colonies are counted. To validate the test, reference mutagens were tested in parallel to the test item.
During the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 06 February 2018 to 21 February 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- (1997)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Liver homogenates from rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Experiment I (plate incorporation test):
All strains with and without S9: 3, 10, 33, 100, 333, 1000, 2500 and 5000 µg/plate
Experiment II (pre-incubation test):
All strains without S9: 3, 10; 33; 100; 333; 1000; 2500 and 5000 μg/plate
Strains TA 1535, TA 1537, and TA 100 with S9 mix: 3; 10; 33; 100; 333; and 1000 μg/plate
Strain TA 98 and WP2 uvrA with S9 mix: 10; 33; 100; 333; 1000; and 2500 μg/plate
Top dose concentrations based on results of the initial toxicity test. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen based on its solubility properties and its nontoxicity to the bacteria - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine (-S9 at 10ug/plate in TA98 and 50 ug/plate in TA1537); methyl methane sulfonate (-S9 at 2.0uL/plate in WP2 uvrA); 2-aminoanthracene (+S9 at 2.5 ug/plate in all strains)
- Remarks:
- The positive control 2-aminoanthracene was only tested with metabolic activation.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium; in agar (plate incorporation)
- Cell density at seeding: 108-109 cells/mL
DURATION
- Preincubation period: 60 minutes
- Exposure duration: 48 hours
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): Not applicable
- Fixation time (start of exposure up to fixation or harvest of cells): Not applicable
NUMBER OF REPLICATIONS: 3 replicate plates were kept in the dark for 48 hours at 37 ºC
DETERMINATION OF CYTOTOXICITY
- Method: manually counting cells and observing the reduction in the number of revertants.
- Any supplementary information relevant to cytotoxicity: Not specified
OTHER EXAMINATIONS: Precipitation of the test item was observed in the incubated overlay agar plate in both experiments. The undissolved particles had no influence on the results.
- Rationale for test conditions:
- Following standard guidelines
- Evaluation criteria:
- The number of revertant colonies on the plates, with and without the test compound, were compared to evaluate mutagenicity. A reduction in the number of revertant colonies and/or a diminution of the background lawn was taken as an indication of cytotoxicity.
- Statistics:
- Not reported
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Not specified
- Effects of osmolality: Not specified
- Evaporation from medium: Not specified
- Water solubility: Not specified
- Precipitation: The test item showed signs of precipitation in experiment I (with metabolising system) and II (with metabolising system). The undissolved particulates had no effect on the recorded data.
- Definition of acceptable cells for analysis: Not specified
- Other confounding effects: Not specified
HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: The data set without S9 are: TA 1535 (334-1816); TA 1537 (43-157); TA 98 (211-627); TA 100 (498-2767); WP2 uvrA. The data set with S9 are: TA 1535 (176-668); TA 1537 (83-434); TA 98 (360-6586); TA 100 (536-6076); WP2 uvrA (167-1265).
- Negative (solvent/vehicle) historical control data: The data set without S9 are: TA 1535 (6-25); TA 1537 (6-19); TA 98 (13-43); TA 100 (78-209); WP2 uvrA (27-63). The data set with S9 are: TA 1535 (7-26); TA 1537 (7-30); TA 98 (15-58); TA 100 (73-208); WP2 uvrA (28-72).
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: Revertant colonies - Conclusions:
- Under the reported experimental conditions, no biological relevant increase in the number of revertant colonies were observed. Therefore, the test item is considered to not induce mutagenic effects via the processes of base pair changes or frameshifts within the genome of the tested amino stains used up to the highest concentration (5000 µg/plate).
- Executive summary:
The potential mutagenicity of the test item was investigated in an Ames test with the Salmonella typhimurium strains (TA 1535, TA 1537, TA 98, TA 100 and TA 102) and Escherichia coli strain (WP2uvrA) in the presence and absence of a metabolising system in the concentration range of 3-5000 µg/plate. Each assay was observed for precipitation, normal background lawn and for the number of revertant colonies. Precipitation was observed in both experiments.
Under the reported experimental conditions, no biological relevant increase in the number of revertant colonies were observed. Therefore, the test item is considered to not induce mutagenic effects via the processes of base pair changes or frameshifts within the genome of the tested amino stains used up to the highest concentration (5000 µg/plate).
This study (2018) is GLP-compliant and follows the OECD Test Guideline 471 and is therefore reliable without restrictions (Klimisch 1).
Reference
Table 1- Induction of revertants in Salmonella typhimurium and Escherichia coli by the test item in the absence of a metabolising system (Experiment I)
Strain |
Dose level per plate (µg) |
Mean revertants per plate |
Standard deviation |
Ratio treated/solvent |
Individual revertant colony counts |
TA 1535 |
3 |
9.7 |
2.5 |
0.9 |
7,10, 12 |
10 |
10.0 |
3.6 |
0.9 |
14,9,7 |
|
33 |
14.7 |
1.2 |
1.4 |
14,16,14 |
|
100 |
9.0 |
4.4 |
0.8 |
6,7,14 |
|
333 |
4.7 |
0.6 |
0.4 |
5,4,5 |
|
1000 |
8.3 |
1.2 |
0.8 |
7 R, 9 R, 9 R |
|
2500 |
8.7 |
1.5 |
0.8 |
7 M R,9 M R, 10 MR |
|
5000 |
6.7 |
1.2 |
0.6 |
6 M R, 6 M R, 8 M R |
|
Solvent control |
10.7 |
1.5 |
|
9,12,11 |
|
Negative control |
8.3 |
1.2 |
|
9,9,7 |
|
TA 1537 |
3 |
7.7 |
1.2 |
0.9 |
9,9,7 |
10 |
10.7 |
0.6 |
1.2 |
11,10,11 |
|
33 |
5.3 |
0.6 |
0.6 |
6,5,5 |
|
100 |
8.3 |
2.1 |
0.9 |
6,9,10 |
|
333 |
6.7 |
2.1 |
0.7 |
6,5,9 |
|
1000 |
3.7 |
1.5 |
0.4 |
5 R, 2 R, 4 R |
|
2500 |
6.0 |
1.0 |
0.7 |
5 R, 7 R, 6R |
|
5000 |
4.3 |
2.1 |
0.5 |
6 R, 5 R, 2 R |
|
Solvent control |
9.0 |
0.0 |
|
9, 9, 9 |
|
Negative control |
7.3 |
2.3 |
|
6, 6, 10 |
|
TA 98 |
3 |
19.3 |
4.7 |
0.9 |
14, 23, 21 |
10 |
20.3 |
5.5 |
0.9 |
26, 15, 20 |
|
33 |
19.3 |
4.0 |
0.9 |
15, 20, 23 |
|
100 |
24.7 |
7.5 |
1.1 |
25, 17, 32 |
|
333 |
18.7 |
3.5 |
0.9 |
22, 15, 19 |
|
1000 |
21.0 |
6.2 |
1.0 |
14 R, 26 R, 23 R |
|
2500 |
15.0 |
5.3 |
0.7 |
17 R, 19 R, 9 R |
|
5000 |
10.0 |
1.0 |
0.5 |
11 R, 10 R, 9 R |
|
Solvent control |
21.7 |
5.8 |
|
25, 25, 15 |
|
Negative control |
29.3 |
7.1 |
|
37, 28, 23 |
|
TA 100 |
3 |
136.7 |
22.9 |
0.9 |
163, 121, 126 |
10 |
148.3 |
15.6 |
1.0 |
150, 163, 132 |
|
33 |
137.3 |
15.5 |
0.9 |
150, 142, 120 |
|
100 |
154.7 |
8.7 |
1.0 |
145, 157, 162 |
|
333 |
107.0 |
5.2 |
0.7 |
104, 104, 113 |
|
1000 |
32.3 |
10.0 |
0.2 |
40 R, 36 R, 21 R |
|
2500 |
34.3 |
8.0 |
0.2 |
42 R, 26 R, 35 R |
|
5000 |
26.7 |
4.7 |
0.2 |
32 R, 25 R, 23 R |
|
Solvent control |
153.7 |
28.3 |
|
146, 130, 185 |
|
Negative control |
181.7 |
3.2 |
|
183, 178, 184 |
|
WP2 uvrA |
3 |
22.0 |
3.0 |
0.7 |
19, 22, 25 |
10 |
25.0 |
4.4 |
0.8 |
23, 22, 30 |
|
33 |
30.0 |
5.3 |
1.0 |
26, 28, 36 |
|
100 |
31.0 |
4.0 |
1.0 |
27,31,35 |
|
333 |
27.0 |
1.0 |
0.9 |
26,27,28 |
|
1000 |
23.7 |
8.3 |
0.8 |
21,33,17 |
|
2500 |
22.0 |
1.0 |
0.7 |
21, 33, 22 |
|
5000 |
14.0 |
3.5 |
0.5 |
16, 10, 16 |
|
Solvent control |
29.7 |
3.5 |
|
33, 26, 30 |
|
Negative control |
37.0 |
6.1 |
|
41, 40, 30 |
M= Manuel count
R= Reduced background growth
P= Precipitate
Table 2- Induction of revertants inSalmonella typhimuriumandEscherichia coliby the test item in the presence of a metabolising system (Experiment I)
Strain |
Dose level per plate (µg) |
Mean revertants per plate |
Standard deviation |
Ratio treated/solvent |
Individual revertant colony counts |
TA 1535 |
3 |
11.3 |
4.0 |
1.0 |
7,10, 15 |
10 |
12.3 |
2.9 |
1.1 |
14,14,9 |
|
33 |
9.0 |
3.0 |
0.8 |
9,12,6 |
|
100 |
11.7 |
2.5 |
1.0 |
12,9,14 |
|
333 |
10.7 |
5.5 |
0.9 |
16,5,11 |
|
1000 |
3.3 |
1.5 |
0.3 |
3 M R, 5 M R, 2 M R |
|
2500 |
0.0 |
0.0 |
0.0 |
0 R,0 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R P, 0 R P, 0 R P |
|
Solvent control |
11.3 |
5.1 |
|
7,17,10 |
|
Negative control |
10.0 |
1.0 |
|
10,9,11 |
|
TA 1537 |
3 |
14.0 |
1.7 |
1.2 |
15,15,12 |
10 |
8.7 |
1.5 |
0.7 |
7,10,9 |
|
33 |
10.0 |
1.0 |
0.9 |
9,10,11 |
|
100 |
9.3 |
3.8 |
0.8 |
5,12,11 |
|
333 |
12.0 |
2.0 |
1.0 |
12,14,10 |
|
1000 |
2.3 |
0.6 |
0.2 |
3 M R, 2 M R, 2 M R |
|
2500 |
0.7 |
1.2 |
0.1 |
0 R, 2 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R P, 0 R P, 0 R P |
|
Solvent control |
11.7 |
2.5 |
|
9, 14, 12 |
|
Negative control |
9.7 |
3.2 |
|
12,11,6 |
|
TA 98 |
3 |
33.0 |
8.9 |
1.3 |
36, 40,23 |
10 |
30.0 |
2.0 |
1.2 |
28,30,32 |
|
33 |
34.3 |
6.4 |
1.3 |
38,38,27 |
|
100 |
26.7 |
4.7 |
1.0 |
23,32,25 |
|
333 |
28.0 |
11.5 |
1.1 |
40,27,17 |
|
1000 |
11.7 |
2.5 |
0.5 |
12 M R, 9 M R, 14 M R |
|
2500 |
2.3 |
1.2 |
0.1 |
1 M R, 3 M R, 3 M R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R P, 0 R P, 0 R P |
|
Solvent control |
25.7 |
5.5 |
|
31,20,26 |
|
Negative control |
32.0 |
4.0 |
|
36,28,32 |
|
TA 100 |
3 |
142.3 |
16.7 |
1.0 |
161, 137, 129 |
10 |
116.0 |
4.4 |
0.8 |
121, 113, 114 |
|
33 |
123.3 |
10.1 |
0.9 |
122, 134, 114 |
|
100 |
135.3 |
7.1 |
1.0 |
143, 129, 134 |
|
333 |
100.3
|
21.0 |
0.7 |
79, 121, 101 |
|
1000 |
27.0 |
8.2 |
0.2 |
36 M R, 25 M R, 20 M R |
|
2500 |
0.7 |
0.6 |
0.0 |
1 R, 1 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R P, 0 R P, 0 R P |
|
Solvent control |
137.7 |
8.6 |
|
136, 147, 130 |
|
Negative control |
157.7 |
14.2 |
|
173, 155, 145 |
|
WP2 uvrA |
3 |
33.0 |
2.0 |
1.1 |
35,33,31 |
10 |
30.7 |
2.3 |
1.0 |
28,32,32 |
|
33 |
39.7 |
8.1 |
1.3 |
47,31,41 |
|
100 |
33.7 |
9.5 |
1.1 |
41,23,37 |
|
333 |
27.3 |
8.1 |
0.9 |
36,26,20 |
|
1000 |
23.0 |
3.6 |
0.7 |
22 R, 27 R, 20 R |
|
2500 |
6.7 |
0.6 |
0.2 |
7 M R, 7 M R, 6 M R |
|
5000 |
7.3 |
0.6 |
0.2 |
8 M R P, 7 M R P, 7 M R P |
|
Solvent control |
31.3 |
4.6 |
|
26,40,28 |
|
Negative control |
40.3 |
3.8 |
|
43, 42, 36 |
M= Manuel count
R= Reduced background growth
P= Precipitate
Table 3- Induction of revertants in Salmonella typhimurium and Escherichia coli by the test item in the absence of a metabolising system (Experiment II)
Strain |
Dose level per plate (µg) |
Mean revertants per plate |
Standard deviation |
Ratio treated/solvent |
Individual revertant colony counts |
TA 1535 |
3 |
9.3 |
4.5 |
0.8 |
9,5,14 |
10 |
8.7 |
3.2 |
0.8 |
5,10,11 |
|
33 |
10.7 |
0.6 |
1.0 |
10,11,11 |
|
100 |
9.3 |
2.1 |
0.8 |
10,11,7 |
|
333 |
4.0 |
3.0 |
0.4 |
7 R,4 R,1 R |
|
1000 |
0.3 |
0.6 |
0.0 |
1 R, 0 R, 0 R |
|
2500 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
Solvent control |
11.0 |
1.0 |
|
12,10,11 |
|
Negative control |
12.0 |
4.4 |
|
10,17,9 |
|
TA 1537 |
3 |
8.7 |
3.5 |
1.0 |
9,12,5 |
10 |
7.3 |
1.5 |
0.8 |
9,6,7 |
|
33 |
8.3 |
3.1 |
0.9 |
11,5,9 |
|
100 |
8.7 |
3.5 |
1.0 |
9,5,12 |
|
333 |
5.7 |
2.9 |
0.6 |
9,5,4 |
|
1000 |
0.3 |
0.6 |
0.0 |
0 R, 1 R, 0 R |
|
2500 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R, 0 R ,0 R |
|
Solvent control |
9.0 |
1.7 |
|
10,10,7 |
|
Negative control |
10.0 |
3.6 |
|
7,14,9 |
|
TA 98 |
3 |
20.7 |
1.2 |
0.8 |
20,20,22 |
10 |
29.0 |
3.6 |
1.2 |
28,33,26 |
|
33 |
24.3 |
6.4 |
1.0 |
28,17,28 |
|
100 |
26.7 |
2.9 |
1.1 |
25,30,25 |
|
333 |
14.7 |
4.6 |
0.6 |
20,12,12 |
|
1000 |
0.7 |
1.2 |
0.0 |
2 R, 0 R, 0 R |
|
2500 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
Solvent control |
24.3 |
3.2 |
|
28,22,23 |
|
Negative control |
28.0 |
5.3 |
|
32,22,30 |
|
TA 100 |
3 |
120.0 |
5.2 |
0.9 |
126,117,117 |
10 |
134.7 |
16.8 |
1.0 |
120,131,153 |
|
33 |
137.0 |
1.7 |
1.0 |
135,138,138 |
|
100 |
120.0 |
9.5 |
0.9 |
111,130,119 |
|
333 |
47.3 |
4.5 |
0.3 |
52,47,43 |
|
1000 |
9.3 |
2.5 |
0.1 |
12 R, 9 R, 7 R |
|
2500 |
0.3 |
0.6 |
0.0 |
1 R, 0 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R,0 R, 0 R |
|
Solvent control |
137.3 |
8.0 |
|
129,138,145 |
|
Negative control |
203.7 |
35.0 |
|
169,239,203 |
|
WP2 uvrA |
3 |
24.0 |
3.5 |
0.9 |
28,22,22 |
10 |
24.3 |
4.0 |
0.9 |
25,20,28 |
|
33 |
29.0 |
2.6 |
1.1 |
31,26,30 |
|
100 |
29.3 |
9.3 |
1.1 |
19,32,37 |
|
333 |
18.3 |
4.2 |
0.7 |
15,17,23 |
|
1000 |
0.7 |
0.6 |
0.0 |
0 R, 1 R, 1 R |
|
2500 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
5000 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
Solvent control |
27.3 |
0.6 |
|
27,27,28 |
|
Negative control |
31.0 |
1.0 |
|
31,32,30 |
R= Reduced background growth
Table 4- Induction of revertants in Salmonella typhimurium and Escherichia coli by the test item in the absence of a metabolising system (Experiment II)
Strain |
Dose level per plate (µg) |
Mean revertants per plate |
Standard deviation |
Ratio treated/solvent |
Individual revertant colony counts |
TA 1535 |
3 |
10.3 |
1.5 |
1.0 |
12,9,10 |
10 |
9.7 |
3.2 |
1.0 |
11,6,12 |
|
33 |
11.3 |
5.5 |
1.1 |
15,5,14 |
|
100 |
11.7 |
2.9 |
1.2 |
15,10,10 |
|
333 |
10.3 |
4.7 |
1.0 |
14,5,12 |
|
1000 |
1.0 |
1.0 |
0.1 |
0 R, 2 R, 1 R |
|
Solvent control |
10.0 |
1.0 |
|
10,9,11 |
|
Negative control |
9.7 |
3.2 |
|
11,12,6 |
|
TA 1537 |
3 |
14.0 |
2.0 |
0.9 |
14,16,12 |
10 |
16.0 |
2.6 |
1.1 |
15,19,14 |
|
33 |
11.7 |
0.6 |
0.8 |
11,12,12 |
|
100 |
13.0 |
2.6 |
0.9 |
12,11,16 |
|
333 |
7.0 |
2.0 |
0.5 |
9,7,5 |
|
1000 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
Solvent control |
15.0 |
2.6 |
|
12,17,16 |
|
Negative control |
16.3 |
4.6 |
|
19,11,19 |
|
TA 98 |
10 |
40.7 |
5.1 |
1.1 |
42,35,45 |
33 |
42.3 |
4.0 |
1.2 |
47,40,40 |
|
100 |
36.0 |
7.9 |
1.0 |
30,33,45 |
|
333 |
13.3 |
2.9 |
0.4 |
10,15,15 |
|
1000 |
1.3 |
0.6 |
0.0 |
1 R, 1R, 2 R |
|
2500 |
0.3 |
0.6 |
0.0 |
0 R, 0 R, 1 R |
|
Solvent control |
36.7 |
3.5 |
|
40, 33, 37 |
|
Negative control |
46.3 |
3.8 |
|
48, 49, 42 |
|
TA 100 |
3 |
112.0 |
12.1 |
0.9 |
105, 126, 105 |
10 |
125.3 |
18.6 |
1.0 |
146, 120, 110 |
|
33 |
127.7 |
7.1 |
1.0 |
129, 134, 120 |
|
100 |
96.3 |
14.5 |
1.7 |
96, 111, 82 |
|
333 |
17.0 |
3.6 |
0.1 |
14, 16, 21 |
|
1000 |
0.3 |
0.6 |
0.0 |
1 R, 0 R, 0 R |
|
Solvent control |
130.7 |
6.1 |
|
136, 132, 124 |
|
Negative control |
189.0 |
1.0 |
|
190, 188, 189 |
|
WP2 uvrA |
10 |
31.7 |
9.0 |
0.8 |
42,27,26 |
33 |
36.3 |
11.5 |
0.9 |
36,48,25 |
|
100 |
36.7 |
5.0 |
0.9 |
36,32,42 |
|
333 |
38.3 |
11.0 |
0.9 |
31,33,51 |
|
1000 |
18.0 |
3.6 |
0.4 |
14,21,19 |
|
2500 |
0.0 |
0.0 |
0.0 |
0 R, 0 R, 0 R |
|
Solvent control |
41.0 |
7.0 |
|
36,38,49 |
|
Negative control |
46.7 |
1.5 |
|
45,48,47 |
R= Reduced background growth
Table 5- Concentrations where the test item showed reduced background growth
Strain |
Experiment 1 |
Experiment 2 |
||
|
Without S9 mix |
With S9 mix |
Without S9 mix |
With S9 mix |
TA 1535 |
1000-5000 |
1000-5000 |
333-5000 |
1000 |
TA 1537 |
1000-5000 |
1000-5000 |
1000-5000 |
1000 |
TA 98 |
1000-5000 |
1000-5000 |
1000-5000 |
1000-2500 |
TA 100 |
1000-5000 |
1000-5000 |
1000-5000 |
1000 |
EP2 uvrA |
/ |
1000-5000 |
1000-5000 |
2500 |
Table 6- Concentrations where the test item showed toxic effects based on the reduction in the number of revertants
Strain |
Experiment 1 |
Experiment 2 |
||
|
Without S9 mix |
With S9 mix |
Without S9 mix |
With S9 mix |
TA 1535 |
333 |
1000-5000 |
333-5000 |
1000 |
TA 1537 |
1000 |
1000-5000 |
1000-5000 |
1000 |
TA 98 |
/ |
2500-5000 |
1000-5000 |
333-2500 |
TA 100 |
1000-5000 |
1000-5000 |
333-5000 |
333-1000 |
EP2 uvrA |
/ |
2500-5000 |
1000-5000 |
1000-2500 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
The test item precipitated in the overlay agar in the test tubes in experiment I from 1000 to 5000 μg/plate with S9 mix and in experiment II from 2500 to 5000 μg/plate without S9 mix respectively at 2500 μg/plate with S9 mix. Precipitation of the test item in the overlay agar on the incubated agar plates was observed in experiment I at 5000 μg/plate with S9 mix. In experiment II no precipitation of the test item was observed on the incubated agar plates up to the highest investigated dose. The undissolved particles had no influence on the data recording.
The plates incubated with the test item showed reduced background growth in all strains used with and without S9 mix.
Toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in all strains with and without metabolic activation (S9 mix).
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
Justification for classification or non-classification
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with the test item at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used and is, therefore, considered to be non-mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.